Sophia Genetics (Sophia Genetics) Long-Term Capital Lease Obligation : $14.74 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sophia Genetics Long-Term Capital Lease Obligation?

Sophia Genetics's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $14.74 Mil.

Sophia Genetics's quarterly Long-Term Capital Lease Obligation increased from Sep. 2023 ($14.96 Mil) to Dec. 2023 ($15.67 Mil) but then declined from Dec. 2023 ($15.67 Mil) to Mar. 2024 ($14.74 Mil).

Sophia Genetics's annual Long-Term Capital Lease Obligation increased from Dec. 2021 ($11.25 Mil) to Dec. 2022 ($14.05 Mil) and increased from Dec. 2022 ($14.05 Mil) to Dec. 2023 ($15.67 Mil).

Sophia Genetics Long-Term Capital Lease Obligation Historical Data

The historical data trend for Sophia Genetics's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sophia Genetics Long-Term Capital Lease Obligation Chart

Sophia Genetics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

3.66

2.88

11.25

14.05

15.67

Sophia Genetics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial													14.77	16.36	14.96	15.67	14.74

Sophia Genetics (NAS:SOPH) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Sophia Genetics Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Sophia Genetics's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Sophia Genetics (Sophia Genetics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sophia Genetics SA (NAS:SOPH) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

90B:Germany

Address

Rue du Centre 172, Saint-Sulpice, CHE, CH-1025

Website

https://www.sophiagenetics.com

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities.